OrbiMed Capital GP VII LLC, Director, 10% Owner at Theseus Pharmaceuticals, Inc. (THRX), bought 281,834 shares at $9.97 ($2.8M) on 2022-01-21, disclosed to the SEC on 2022-01-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.97 | 11,521 | $115K | 4.1% |
| 2 | $9.97 | 11,521 | $115K | 4.1% |
| 3 | $9.95 | 35,000 | $348K | 12.4% |
| 4 | $9.97 | 111,896 | $1.1M | 39.7% |
| 5 | $9.97 | 111,896 | $1.1M | 39.7% |
| Total | $9.97 avg | 281,834 |
| $2.8M |
| 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |